Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes global epidemics
of a debilitating polyarthritis in humans. As there is a pressing need for the development …

Antibody protection against flaviviruses is associated with the development of neutralizing
antibodies against the viral envelope (E) protein. Prior studies with West Nile virus (WNV) …

Dengue virus (DENV) is the most prevalent insect-transmitted viral disease in humans globally,
and currently no specific therapy or vaccine is available. Protection against DENV and …

Zika virus (ZIKV) is a re-emerging virus that has recently spread into dengue virus (DENV)
endemic regions and cross-reactive antibodies (Abs) could potentially affect ZIKV …

CD4 T cells have been shown to be necessary for the prevention of encephalitis during West
Nile virus (WNV) infection. However, the mechanisms used by Ag-specific CD4 T cells to …

Dengue viruses (DENV) comprise a family of related positive-strand RNA viruses that infect
up to 100 million people annually. Currently, there is no approved vaccine or therapy to …

West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes
increasingly more prevalent over the age of 50 and is 40–50× more prevalent in people …

Chikungunya virus (CHIKV) is a mosquito-transmitted RNA virus that causes acute febrile
infection associated with polyarthralgia in humans. Mechanisms of protective immunity against …

Type I interferon (IFN) signaling coordinates an early antiviral program in infected and uninfected
cells by inducing IFN-stimulated genes (ISGs) that modulate viral entry, replication, and …

Prominent immune alterations associated with aging include the loss of naïve T-cell numbers,
diversity and function. While genetic contributors and mechanistic details in the aging …